Sarcoma  >>  cisplatin  >>  Phase 2
Welcome,         Profile    Billing    Logout  

47 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
cisplatin / Generic mfg.
NCT00002993: Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus

Terminated
2
30
US
cisplatin, doxorubicin hydrochloride, mitomycin C
Gynecologic Oncology Group, National Cancer Institute (NCI)
Sarcoma
01/00
 
NCT00002492: Combination Chemotherapy in Treating Patients With Soft Tissue Sarcoma

Completed
2
US
cisplatin, doxorubicin hydrochloride, isolated limb perfusion, conventional surgery, brachytherapy, radiation therapy
University of Miami
Sarcoma
02/00
02/00
NCT00003776: Combination Chemotherapy and Surgery in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma

Completed
2
US
filgrastim, cisplatin, doxorubicin hydrochloride, ifosfamide, leucovorin calcium, methotrexate, trimetrexate glucuronate, surgical procedure
Memorial Sloan Kettering Cancer Center, National Cancer Institute (NCI)
Sarcoma
03/00
03/00
NCT00165139: Intensive Chemo-Radiotherapy With Peripheral Blood Progenitor Cell Rescue for Children With Advanced Neuroblastoma and Sarcomas

Completed
2
20
US
Vincristine, Cyclophosphamide, Adriamycin, Etoposide (VP-16), Cisplatin, Carboplatin, Melphalan, Ifosfamide, G-CSF (granulocyte-colony stimulating factor), Mesna
Dana-Farber Cancer Institute, Boston Children's Hospital, Children's Hospital of Philadelphia
Neuroblastoma, Ewings Sarcoma, Non-rhabdomyosarcoma Soft Tissue Sarcoma
11/00
02/09
NCT00014313: Chemotherapy in Treating Patients With Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor

Terminated
2
3
Europe
cisplatin, etoposide
European Organisation for Research and Treatment of Cancer - EORTC
Sarcoma
12/02
 
NCT00003624: Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer

Terminated
2
US
amifostine trihydrate, cisplatin, paclitaxel
Gynecologic Oncology Group, National Cancer Institute (NCI)
Cervical Cancer, Endometrial Cancer, Fallopian Tube Cancer, Neurotoxicity, Ovarian Cancer, Primary Peritoneal Cavity Cancer, Sarcoma
01/04
 
NCT00002608: Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors

Completed
2
30
Canada
cisplatin, doxorubicin hydrochloride, tamoxifen citrate, conventional surgery, radiation therapy
Ottawa Regional Cancer Centre
Adrenocortical Carcinoma, Brain and Central Nervous System Tumors, Head and Neck Cancer, Liver Cancer, Malignant Mesothelioma, Pheochromocytoma, Sarcoma
 
04/05
NCT00033644: Combination Chemotherapy Plus Sargramostim in Treating Patients With Cancer of the Uterus

Terminated
2
US, Europe
sargramostim, cisplatin, dacarbazine, doxorubicin hydrochloride, mitomycin C
Gynecologic Oncology Group, National Cancer Institute (NCI)
Sarcoma
10/05
 
NCT00023998: Chemotherapy With or Without Trastuzumab in Treating Patients With Metastatic Osteosarcoma

Completed
2
80
US
doxorubicin hydrochloride, ADM, ADR, Adria, Adriamycin PFS, Adriamycin RDF, cisplatin, CACP, CDDP, CPDD, DDP, methotrexate, amethopterin, Folex, methylaminopterin, Mexate, MTX, leucovorin calcium, CF, CFR, LV, filgrastim, G-CSF, Neupogen, therapeutic conventional surgery, radiation therapy, irradiation, radiotherapy, therapy, radiation, etoposide, EPEG, VP-16, VP-16-213, ifosfamide, Cyfos, Holoxan, IFF, IFX, IPP, trastuzumab, anti-c-erB-2, Herceptin, MOAB HER2, laboratory biomarker analysis
National Cancer Institute (NCI)
Metastatic Osteosarcoma
11/05
05/07
NCT00027703: Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma

Checkmark P2 data (Mesothelioma)
Jun 2012 - Jun 2012: P2 data (Mesothelioma)
Completed
2
106
US
gemcitabine hydrochloride, dFdC, difluorodeoxycytidine hydrochloride, gemcitabine, Gemzar, cisplatin, CACP, CDDP, CPDD, DDP, bevacizumab, anti-VEGF humanized monoclonal antibody, anti-VEGF monoclonal antibody, Avastin, rhuMAb VEGF, placebo, PLCB, laboratory biomarker analysis
National Cancer Institute (NCI)
Advanced Malignant Mesothelioma, Epithelial Mesothelioma, Localized Malignant Mesothelioma, Recurrent Malignant Mesothelioma, Sarcomatous Mesothelioma
05/06
 
NCT00005049: Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer

Completed
2
45
US
carboplatin, cisplatin, floxuridine
NYU Langone Health, National Cancer Institute (NCI)
Colorectal Cancer, Gastric Cancer, Gastrointestinal Carcinoid Tumor, Gastrointestinal Stromal Tumor, Ovarian Cancer, Peritoneal Cavity Cancer, Small Intestine Cancer
11/06
 
NCT00652860: Combination Chemotherapy, Radiation Therapy, and Sargramostim Before and After Surgery in Treating Patients With Soft Tissue Sarcoma That Can Be Removed By Surgery

Completed
2
39
US
aerosol sargramostim, sargramostim, cisplatin, doxorubicin hydrochloride, ifosfamide, mitomycin C, flow cytometry, immunological diagnostic method, laboratory biomarker analysis, adjuvant therapy, multimodality therapy, neoadjuvant therapy, therapeutic conventional surgery, intraoperative radiation therapy, selective external radiation therapy
Mayo Clinic, National Cancer Institute (NCI)
Metastatic Cancer, Sarcoma
11/06
 
NCT00019864: Combination Chemotherapy Before and After Surgery in Treating Patients With Osteosarcoma

Terminated
2
100
US
filgrastim, cisplatin, dexrazoxane hydrochloride, doxorubicin hydrochloride, leucovorin calcium, methotrexate, adjuvant therapy, conventional surgery, neoadjuvant therapy
National Cancer Institute (NCI)
Cardiac Toxicity, Sarcoma
12/06
10/11
NCT00084838: Chemotherapy Combined With Radiation Therapy for Newly Diagnosed CNS AT/RT

Completed
2
25
US
filgrastim, filgrastim XM02, G-CSF, cisplatin, CACP, cis-DDP, cis-diamminedichloro platinum (II), cis-diamminedichloroplatinum, Cis-dichloroammine Platinum (II), Cismaplat, Platinol, cyclophosphamide, Ciclofosfamida, Ciclofosfamide, Claphene, CP monohydrate, CPM, Cyclophospham, Cyclophosphamid monohydrate, Cyclophosphamidum, Cyclophosphan, Cyclophosphanum, Cytophosphane, Mitoxan, Syklofosfamid, Zytoxan, Clafen, Cytoxan, Neosar, cytarabine, arabinofuranosylcytosine, arabinosylcytosine, aracytidine, beta-cytosine arabinoside, cytarabine hydrochloride, cytarabinum, cytosine arabinoside, cytosine arabinosine hydrochloride, Cytosar-U, Tarabine PFS, dexrazoxane hydrochloride, Totect, Zinecard, doxorubicin hydrochloride, Adriamycin PFS, Adriamycin RDF, etoposide, VP-16, leucovorin calcium, folinate calcium, folinic acid, methotrexate, temozolomide, Temodar, Methazolastone, Temodal, TMZ, CCRG-81045, therapeutic hydrocortisone, vincristine sulfate, leurocristine sulfate, Vincasar PFS, radiation therapy, Dactinomycin, ACT-D, actinomycin C1, actinomycin D, actinomycin I1, actinomycin IV, actinomycin X 1, actinomycin-[thr-val-pro-sar-meval], AD, dactinomycine, meractinomycin
Dana-Farber Cancer Institute, National Cancer Institute (NCI)
Central Nervous System Tumor, Pediatric
02/08
03/13
NCT00586846: Phase II Study of Chemotherapy and Pamidronate for the Treatment of Newly Diagnosed Osteosarcoma

Completed
2
40
US
Cisplatin, Doxorubicin, Methotrexate
Memorial Sloan Kettering Cancer Center
Osteosarcoma
02/09
02/09
NCT00072306: Neoadjuvant and Adjuvant Pamidronate With Induction and Maintenance Chemotherapy in Treating Patients With Osteosarcoma

Completed
2
75
US
cisplatin, doxorubicin hydrochloride, methotrexate, pamidronate disodium, adjuvant therapy, conventional surgery, neoadjuvant therapy
Memorial Sloan-Kettering Cancer Center, National Cancer Institute (NCI)
Sarcoma
02/09
 
NCT00267046: Evaluate PKs and Efficacy Assessment of Palifermin in Patients With Sarcoma

Completed
2
49
US
Palifermin, Placebo, Adriamycin (Doxorubicin), Adriamycin, Ifosfamide, Vincristine, Cisplatin, CDDP, Platinol
M.D. Anderson Cancer Center
Sarcoma, Oral Mucositis
07/09
07/09
2009-017437-22: MANAGEMENT OF PRIMARY AND SECUNDARY PERITONEAL CARCINOMATOSIS FROM COLO-RECTAL CANCER, RECURRENT OVARIAN CANCER AND ABDOMINAL SARCOMATOSIS BY CYTOREDUCTIVE SURGERY PLUS HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY

Ongoing
2
60
Europe
Solvent for parenteral use, Solution for injection, CISPLATINO TEVA*EV 50MG 100ML, ADRIBLASTINA*EV FL 10MG+F 5ML, MITOMYCIN C, ELOXATIN*INFUS 1FL 10ML 5MG/ML
AZIENDA OSPEDALIERA DI PERUGIA
Peritoneal carcinomatosis
 
 
GVPS, NCT01192633: Gemcitabine,Vincristine and Cisplatin as Second Line Combination Therapy in Patients With Sarcoma

Unknown status
2
40
RoW
GVP
Fudan University
Sarcoma, Chemotherapy
01/11
01/11
NCT01105390: AMG 102, Pemetrexed Disodium, and Cisplatin in Treating Patients With Malignant Pleural Mesothelioma

Withdrawn
2
0
US
rilotumumab, AMG 102, anti-HGF monoclonal antibody AMG 102, cisplatin, CACP, CDDP, CPDD, DDP, pemetrexed disodium, ALIMTA, LY231514, MTA, laboratory biomarker analysis
National Cancer Institute (NCI)
Advanced Malignant Mesothelioma, Epithelial Mesothelioma, Recurrent Malignant Mesothelioma, Sarcomatous Mesothelioma
05/11
 
NCT00965172: Caphosol in Sarcoma Patients With Mucositis

Completed
2
30
US
Caphosol, calcium phosphate, Baking Soda, Sodium Bicarbonate
M.D. Anderson Cancer Center
Sarcoma, Oral Mucositis
02/12
02/12
NCT00667342: A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma

Completed
2
43
US
Bevacizumab, rhuMAb VEGF, Avastin®, Cisplatin, Platinol-AQ®, Doxorubicin, Adriamycin®, Methotrexate, MTX, Ifosfamide, Ifex®, etoposide, VP-16, Vepesid®, Surgery, Radiotherapy
St. Jude Children's Research Hospital, Genentech, Inc.
Osteosarcoma, Malignant Fibrous Histiocytoma (MFH) of Bone
08/14
08/17
NCT00002601: Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Sarcoma

Completed
2
13
US
filgrastim, cisplatin, doxorubicin hydrochloride, ifosfamide, melphalan, peripheral blood stem cell transplantation
City of Hope Medical Center, National Cancer Institute (NCI)
Sarcoma
09/14
09/14
NCT00511992: Study of Bevacizumab Followed by Bevacizumab Consolidation for Ovarian Cancer

Completed
2
20
US
Avastin, Bevacizumab, Paclitaxel, Cisplatin
University of Oklahoma, Genentech, Inc.
Advanced Ovarian Carcinoma, Primary Peritoneal Carcinoma, Ovarian Carcinosarcoma
08/15
08/15
NCT00003273: Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor

Withdrawn
2
0
US, Canada, RoW
filgrastim, carboplatin, cisplatin, cyclophosphamide, etoposide, leucovorin calcium, methotrexate, temozolomide, thiotepa, vincristine sulfate, autologous bone marrow transplantation, peripheral blood stem cell transplantation, radiation therapy
NYU Langone Health
Brain and Central Nervous System Tumors, Neuroblastoma, Retinoblastoma, Sarcoma
 
 
NCT01848457: Preventing Nephrotoxicity and Ototoxicity From Osteosarcoma Therapy

Completed
2
13
US
Pantoprazole, Protonix IV, High-dose methotrexate infusion duration, Otrexup (PF), Xatmep, Trexall
Children's Hospital of Philadelphia, Gateway for Cancer Research
Osteosarcoma, Nephrotoxicity, Ototoxicity
01/16
10/16
NCT01277744: Pilot Study of Hyperthermic Peritoneal Perfusion (HIPEC) for Adolescent and Young Adults With Desmoplastic Small Round Cell Tumor

Completed
2
22
US
Hyperthermic Peritoneal Perfusion (HIPEC), Cisplatin, Platinol-AQ, Platinol, CDDP
M.D. Anderson Cancer Center
Advanced Cancers, Sarcoma
02/18
02/18
NCT02784015: Response Based Treatment for Children With Unresectable Localized Soft Tissue Sarcoma

Recruiting
2
41
RoW
Cisplatin, Etoposide, Doxorubicin, Cyclophosphamide, Ifosfamide, Carboplatin, Radiotherapy, Thiotepa, Melphalan
Samsung Medical Center
Unresectable Localized Soft Tissue Sarcoma
05/20
05/23
NCT03390946: Feasibility Study of Interval Compressed Regimen Using Four-drugs for Osteosarcoma

Unknown status
2
23
RoW
Poor responder group adjuvant chemotherapy, PR adjuvant four-drug interval-compressed regimen, Good responder group adjuvant chemotherapy, GR adjuvant four-drug interval-compressed regimen
Byung-Kiu Park, Samsung Medical Center, Chungnam National University Hospital
Osteosarcoma, Feasibility, Treatment Response, Biomarker
12/20
12/20
NCT04294511: Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy in the Treatment of Osteosarcoma

Recruiting
2
75
RoW
Camrelizumab in Combination With Neoadjuvant Chemotherapy, PD-1 inhibitor
Sun Yat-sen University, Jiangsu HengRui Medicine Co., Ltd.
Osteosarcoma
03/21
09/23
2021-002366-41: Phase II, multicenter, randomized, open-label study with MAP +/- denosumab regimen for the treatment of patients with metastatic osteosarcoma Studio di fase II, multicentrico, randomizzato, in aperto con regime MAP +/- denosumab per il trattamento dei pazienti con osteosarcoma metastatico

Not yet recruiting
2
112
Europe
CISPLATINO, DENOSUMAB, METHOTREXATE, DOXORUBICINA, [CISPLATINO], [DENOSUMAB], [METHOTREXATE], [ADM], Solution for infusion in administration system, Solution for injection, Concentrate and solvent for solution for infusion, XGEVA - 120 MG - SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - FLACONCINO (VETRO) - 1.7 ML 1 FLACONCINO
ASSOCIAZIONE ITALIANA EMATOLOGIA ONCOLOGIA PEDIATRICA
Metastatic osteosarcoma Osteosarcoma metastatico, Metastatic osteosarcoma Osteosarcoma metastatico, Diseases [C] - Cancer [C04]
 
 
HIPEC/IPHC, NCT02349958: Clinical Trial of Intraperitoneal Hyperthermic Chemotherapy

Unknown status
2
200
US
HIPEC: MMC 30mg @ T0, 10mg @ T45min, HIPEC, HIPEC: MMC + CDDP 30mg @ T0, 10mg @ T45min 50 mg/m2 @T0, HIPEC: CDDP 75 mg/m2 @T0, HIPEC: CDDP+ Doxorubicin 50 mg/m2 @T0 15 mg/m2 @T0
Bay Area Gynecology Oncology
Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer, Uterine Cancer, Mesotheliomas, Gastrointestinal Cancers, Cervical Cancer
01/22
01/22
NCT03809637: A Study of Pemetrexed Plus Cisplatin in Patients With Refractory Soft Tissue Sarcoma

Active, not recruiting
2
37
RoW
Pemetrexed, cisplatin
Yonsei University
Sarcoma
06/22
12/22
NCT03912818: Durvalumab and Standard Chemotherapy Before Surgery in Treating Patients With Variant Histology Bladder Cancer

Terminated
2
7
US
Carboplatin, Carboplat, Carboplatino, Carbosol, Paraplatin, Paraplatine, Cisplatin, Abiplatin, Briplatin, Cis-platinum, Cismaplat, Citoplatino, Plastistil, Platinol, Cystectomy, Doxorubicin, Adriablastin, Hydroxyl Daunorubicin, Rubex, Durvalumab, Imfinzi, MEDI-4736, Gemcitabine, Difluorodeoxycytidine, Gemzar, Methotrexate, Abitrexate, Amethopterin, Brimexate, Methotrexate Methylaminopterin, Metotrexato, Vinblastine, Vincaleucoblastine, Vinblastine Sulfate, vincaleukoblastine, sulfate
Stanford University, AstraZeneca
Bladder Adenocarcinoma, Bladder Mixed Adenocarcinoma, Bladder Squamous Cell Carcinoma, Bladder Urothelial Carcinoma, Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant, Infiltrating Bladder Urothelial Carcinoma With Giant Cells, Infiltrating Bladder Urothelial Carcinoma With Glandular Differentiation, Infiltrating Bladder Urothelial Carcinoma With Trophoblastic Differentiation, Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant, Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant, Infiltrating Bladder Urothelial Carcinoma, Nested Variant, Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant
08/22
08/22
MAPAC, NCT04351308: Comparison of MAPI+Camrelizumab Versus API+Apatinib Versus MAPI in Patients With a Poor Response to Preoperative Chemotherapy for Newly Diagnosed High-grade Osteosarcoma

Recruiting
2
60
RoW
MAPI chemotherapy, Apatinib Mesylate, Camrelizumab
Peking University People's Hospital, Chinese Sarcoma Study Group
Osteosarcoma, Survival, Chemotherapy Effect, Toxicity, Drug
09/22
12/22
ALBATROSS, NCT04605770: Pemetrexed, Cisplatin With Soft Tissue Sarcoma

Recruiting
2
164
RoW
pemetrexed+cisplatin
Yonsei University
Sarcoma,Soft Tissue
11/22
11/22
NCT05241132: Tislelizumab Combined With Chemotherapy in the Treatment of Bone Metastases of Unknown Primary

Recruiting
2
27
RoW
Tislelizumab plus chemotherapy, Cisplatin, Paclitaxel
Wei Xu
Cancer of Unknown Primary, Bone Cancer Metastatic, Tislelizumab, Gene Mutation-Related Cancer, Immune Evasion, Tumor, Chemotherapy Effect
06/23
10/24
ISG/OS-2, NCT01459484 / 2011-001659-36: ABCB1/P-glycoprotein Expression as Biologic Stratification Factor for Patients With Non Metastatic Osteosarcoma

Completed
2
225
Europe
Mifamurtide arm, Methotrexate, Cisplatinum, doxorubicin, ifosfamide, mifamurtide, 3 drugs arm, methotrexate, cisplatin, doxorubicine
Italian Sarcoma Group
Osteosarcoma
04/24
04/24
Pan-MSI-ACSE, NCT06333314: Dostarlimab for Locally Advanced or Metastatic Cancer (non-colorectal/non-endometrial) with Tumor DMMR/MSI

Recruiting
2
120
Europe
Dostarlimab, Chemotherapy
UNICANCER, National Cancer Institute, France, GlaxoSmithKline
Pancreatic Adenocarcinoma, Ampulla of Vater Carcinoma, Adrenocortical Carcinoma, Neuroendocrine Carcinoma, Soft Tissue Sarcoma, Small Bowel Adenocarcinoma, Duodenum Adenocarcinoma, Gastric Adenocarcinoma
10/28
09/30
NCT05926492: A Clinical Study of Surufatinib Combined With Chemotherapy as Neoadjuvant Treatment in Osteosarcoma

Recruiting
2
160
RoW
Surufatinib plus chemotherapy, Arm A, Chemotherapy, Arm B
Second Affiliated Hospital, School of Medicine, Zhejiang University
Osteosarcoma
07/25
07/26
SJATRT, NCT02114229: Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors

Active, not recruiting
2
125
US
alisertib, methotrexate, MTX, cisplatin, Platinol-AQ, carboplatin, paraplatin, cyclophosphamide, cytoxan, etoposide, VP-16, Vepesid, Etoposide phosphate (Etopophos), topotecan, Hycamtin, vincristine, Oncovin, Surgical resection, surgical management, Radiation therapy, Craniospinal irradiation (CSI), Radiotherapy
St. Jude Children's Research Hospital, Millennium Pharmaceuticals, Inc., Takeda Pharmaceuticals U.S.A., Inc.
Malignant Rhabdoid Tumor, Atypical Teratoid Rhabdoid Tumor
09/25
09/27
ChiCTR2400086577: The efficacy and safety study of adebrelimab in combination with chemotherapy and apatinib for perioperative treatment of lung sarcomatoid carcinoma

Recruiting
2
25
 
Pre-surgical neoadjuvant therapy phase1.Adebrelimab: 1200 mg IV, D1, Q3W, treatment for 2-4 cycles; 2. Apatinib: 250 mg, QD, half hour after meal, treatment for 2-4 cycles; 3. albumin paclitaxel: 260 mg/m2, D1, Q3W; 4. cisplatin: 70 mg/m2, D1, Q3W (no more than 130 mg)/carboplatin: 300-400 mg/m2, D1, Q3W.Chemotherapy may be given in split doses before and after surgery for a total of no more than 4 cycles of treatment.Surgery was performed within 6 weeks of the last neoadjuvant dose, and adjuvant therapy was administered within 6 weeks after surgery as assessed by the investigator.Post-surgical adjuvant therapy phase.Treatment regimen determined by the investigator (Adebrelimab1200 mg + apatinib 250 mg for up to 13 cycles is recommended for driver gene-negative patients; adjuvant treatment with TKIs is selected by the investigator for driver gene-positive patients).
Tianjin Medical University General Hospital; Tianjin Medical University General Hospital, Jiangsu Hengrui Medicine Co.,Ltd.
pulmonary sarcomatoid carcinoma
 
 
SWOG S0905, NCT01064648: Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma

Active, not recruiting
1/2
117
US
Cediranib Maleate, AZD2171, AZD2171 Maleate, Recentin, Cisplatin, Abiplatin, Blastolem, Briplatin, CDDP, Cis-diammine-dichloroplatinum, Cis-diamminedichloridoplatinum, Cis-diamminedichloro Platinum (II), Cis-diamminedichloroplatinum, Cis-dichloroammine Platinum (II), Cis-platinous Diamine Dichloride, Cis-platinum, Cis-platinum II, Cis-platinum II Diamine Dichloride, Cismaplat, Cisplatina, Cisplatinum, Cisplatyl, Citoplatino, Citosin, Cysplatyna, DDP, Lederplatin, Metaplatin, Neoplatin, Peyrone's Chloride, Peyrone's Salt, Placis, Plastistil, Platamine, Platiblastin, Platiblastin-S, Platinex, Platinol, Platinol- AQ, Platinol-AQ, Platinol-AQ VHA Plus, Platinoxan, Platinum, Platinum Diamminodichloride, Platiran, Platistin, Platosin, Laboratory Biomarker Analysis, Pemetrexed Disodium, Alimta, Almita, LY231514, N-[4-[2-(2-Amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic Acid Disodium Salt, Placebo Administration
National Cancer Institute (NCI)
Epithelioid Mesothelioma, Pleural Malignant Mesothelioma, Recurrent Malignant Mesothelioma, Sarcomatoid Mesothelioma
06/18
03/25
2102-ONC-102, NCT03684811: A Study of FT-2102 in Patients With Advanced Solid Tumors and Gliomas With an IDH1 Mutation

Completed
1/2
93
Europe, US, RoW
FT-2102, Azacitidine, Vidaza, Nivolumab, Opdivo, Gemcitabine and Cisplatin, Gemzar and Platinol
Forma Therapeutics, Inc.
Cohort 1a and 1b: Glioma (Advanced Gliomas and Glioblastoma Multiforme), Cohort 2a and 2b: Hepatobiliary Tumors (Hepatocellular Carcinoma, Bile Duct Carcinoma, Intrahepatic Cholangiocarcinoma, Other Hepatobiliary Carcinomas), Cohort 3a and 3b: Chondrosarcoma, Cohort 4a and 4b: Intrahepatic Cholangiocarcinoma, Cohort 5a: Other Non-Central Nervous System Solid Tumors With IDH1 Mutations
05/21
06/22
IACE-OS, NCT06562673: Intra-arterial Cisplatin Plus Rh-endostatin Combined With Systematic Chemotherapy in Osteosarcoma

Not yet recruiting
1/2
10
RoW
intra-arterial cisplatin plus anti-angiogenesis inhibitor rh-endostatin (Endostar), intra-arterial treatment
Shanghai 6th People's Hospital
Osteosarcoma, Bone Cancer
04/25
04/25
ImmunoSarc, NCT03277924 / 2016-004040-10: Trial of Sunitinib and/or Nivolumab Plus Chemotherapy in Advanced Soft Tissue and Bone Sarcomas

Completed
1/2
197
Europe
Sunitinib 37.5 MG, Sunitinib 25 MG [Sutent], Sutent, Nivolumab 100 MG/10 ML [Opdivo], Opdivo, Epirubicin, Ifosfamide, Doxorubicin, Dacarbazine, Cisplatin, Methotrexate
Grupo Espanol de Investigacion en Sarcomas
Soft Tissue Sarcoma, Bone Sarcoma
06/24
06/24
NCT03965234: Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases

Recruiting
1/2
99
US
Cisplatin, Abiplatin, Blastolem, Briplatin, CDDP, Cis-diammine-dichloroplatinum, Cis-diamminedichloridoplatinum, Cis-diamminedichloro Platinum (II), Cis-diamminedichloroplatinum, Cis-dichloroammine Platinum (II), Cis-platinous Diamine Dichloride, Cis-platinum, Cis-platinum II, Cis-platinum II Diamine Dichloride, Cismaplat, Cisplatina, Cisplatinum, Cisplatyl, Citoplatino, Citosin, Cysplatyna, DDP, Lederplatin, Metaplatin, Neoplatin, Peyrone's Chloride, Peyrone's Salt, Placis, Plastistil, Platamine, Platiblastin, Platiblastin-S, Platinex, Platinol, Platinol- AQ, Platinol-AQ, Platinol-AQ VHA Plus, Platinoxan, Platinum, Platinum Diamminodichloride, Platiran, Platistin, Platosin, Isolated Chemotherapeutic Lung Perfusion, isolated lung perfusion, Metastasectomy
Roswell Park Cancer Institute
Metastatic Bone Sarcoma, Metastatic Malignant Neoplasm in the Lung, Metastatic Soft Tissue Sarcoma, Metastatic Unresectable Sarcoma, Resectable Sarcoma, Colorectal Cancer
05/29
05/30

Download Options